IRCT201611155623N93已完成3 期
Clinical trial of the effect of coenzyme Q10 supplementation compared with the placebo on gene expression involved in insulin, lipid and inflammation signaling pathway in patients with diabetic nephropathy
Vice chancellor for research, Kashan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 85 years（—）
- 性别
- All
入选标准
- •Patients with diabetic nephropathy
- •Aged 40 to 80 years
排除标准
- •Consumption of any nutritional supplements within 3 months
- •History of active infection within 3 months
- •History of hospital admission within 3 months
- •Malignancy and/or liver cirrhosis
- •Subjects with uncontrolled diabetes
- •Pregnant women
研究者
相似试验
已完成
2 期
Effect of supplementation in treatment of patients with polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovary syndromeIRCT201612315623N97Vice chancellor of research, Bushehr University of Medical Sciences40
已完成
3 期
Effect of supplementation in treatment of patients with diabetic nephropathyDiabetic nephropathy.Glomerular disorders in diabetes mellitus (E10-E14 with common fourth character .2+)N08.3IRCT201606205623N85Vice chancellor for research, Kashan University of Medical Sciences50
已完成
3 期
Effect of supplementation in treatment of women with polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovarian syndromeE28.2IRCT201605225623N80Vice chancellor for research, Arak University of Medical Sciences60
已完成
3 期
Effect of Q10 supplementation in treatment of women with polycystic ovary syndromeIRCT20170513033941N36Iran University of Medical Sciences60
已完成
3 期
Effect of Q10 supplementation in treatment of women with polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovarian syndromeIRCT20170513033941N21Kashan University of Medical Sciences60